Clinical Research Directory
Browse clinical research sites, groups, and studies.
sTErnAl heMostasiS Trial
Sponsor: WakeMed Health and Hospitals
Summary
Sternal bleeding remains an unsolved problem for cardiac surgery teams costing operative time, blood loss, and distraction from the critical operative field. As such, the following is an investigator-initiated trial to determine whether application of a topical hemostatic agent reduces sternal bleeding during cardiac surgery using sternotomy approach.
Official title: sTErnAl heMostasiS Trial (TEAMS Trial)
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-10-17
Completion Date
2026-09
Last Updated
2025-09-11
Healthy Volunteers
No
Conditions
Interventions
Hemoblast Bellows application
Hemoblast bellows is a hemostatic agent clinically proven effective on the validated SPOT GRADE scale for minimal, mild, and moderate bleeding. Patients will have the Hemoblast bellows applied during on pump sternotomy surgery.
Locations (1)
WakeMed Health and Hospitals
Raleigh, North Carolina, United States